Diane Bronzert
About
In The Last Decade
Diane Bronzert
29 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.0k
- Genetics 897
- Oncology 834
- Endocrinology, Diabetes and Metabolism 378
- Cancer Research 327
Countries citing papers authored by Diane Bronzert
This map shows the geographic impact of Diane Bronzert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Bronzert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Bronzert more than expected).
Fields of papers citing papers by Diane Bronzert
This network shows the impact of papers produced by Diane Bronzert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Bronzert. The network helps show where Diane Bronzert may publish in the future.
Co-authorship network of co-authors of Diane Bronzert
This figure shows the co-authorship network connecting the top 25 collaborators of Diane Bronzert. A scholar is included among the top collaborators of Diane Bronzert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Bronzert. Diane Bronzert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 81 | |
| 2 | 118 | |
| 3 | 43 | |
| 4 | Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. | 79 |
| 5 | 65 | |
| 6 | 108 | |
| 7 | 254 | |
| 8 | 125 | |
| 9 | 14 | |
| 10 | Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products. | 45 |
| 11 | 2 | |
| 12 | 63 | |
| 13 | Purification and properties of estrogen-responsive cytoplasmic thymidine kinase from human breast cancer. | 43 |
| 14 | 120 | |
| 15 | Direct inhibition of growth and antagonism of insulin action by glucocorticoids in human breast cancer cells in culture. | 51 |
| 16 | Purification and general properties of estrogen responsive cytoplasmic thymidine kinase from human breast cancer | 1 |
| 17 | Casein production by human breast cancer. | 32 |
| 18 | Diagnostic applications of calcitonin immunoassay. | 1 |
| 19 | 21 | |
| 20 | 79 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.